Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:oxycodone
|
| gptkbp:ATCCode |
N02AA05
|
| gptkbp:contraindication |
acute asthma
severe respiratory depression |
| gptkbp:controlledSubstanceSchedule |
yes
|
| gptkbp:countryOfOperation |
gptkb:Australia
gptkb:United_Kingdom |
| gptkbp:drugClass |
opioid
|
| gptkbp:duration |
3-6 hours
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:form |
capsule
oral solution |
| gptkbp:halfLife |
3-4.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
OxyNorm
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Mundipharma
|
| gptkbp:metabolism |
liver
|
| gptkbp:onset |
10-15 minutes
|
| gptkbp:pregnancyCategory |
gptkb:B_(UK)
gptkb:C_(Australia) |
| gptkbp:prescriptionRequired |
yes
|
| gptkbp:riskFactor |
addiction
overdose |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation drowsiness respiratory depression |
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:Purdue_Pharma
|
| gptkbp:bfsLayer |
6
|